M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Response to: 'Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al' by Wei et al
Laure Gossec,Xenofon Baraliakos,Iain B. McInnes,Andreas Kerschbaumer,Maarten de Wit,Maxime Dougados,Jette Primdahl,Désirée van der Heijde,Josef S Smolen +8 more
TL;DR: This correspondence raises some interesting points about the role of cyclosporine A in the treatment of patients with psoriatic disease and suggests that CsA could be proposed for PsA.
Journal ArticleDOI
Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures
Sandrine Malochet-Guinamand,Bruno Pereira,Zuzana Tatar,Anne Tournadre,Anna Molto,Maxime Dougados,Martin Soubrier +6 more
TL;DR: A high prevalence (around 50%) of low BMD in SpA is found and lateral spine BMD measurement did little to improve the detection of osteopenia in women, and the sample size was not large enough to draw definite conclusions.
Journal ArticleDOI
Concordance between abdominal scintigraphy using technetium-99m hexamethylpropylene amine oxime-labelled leucocytes and ileocolonoscopy in patients with spondyloarthropathies and without clinical evidence of inflammatory bowel disease.
TL;DR: ASTLL may be an interesting tool to detect subclinical gut inflammation in patients with SpA and without clinical evidence of inflammatory bowel disease (IBD).
Journal ArticleDOI
Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study.
Maxime Dougados,Désirée van der Heijde,Joachim Sieper,Jürgen Braun,Gustavo Citera,Jan T. M. Lenaerts,Filip Van den Bosch,James Cheng-Chung Wei,Ron Pedersen,R. Bonin,Heather Jones,Lisa Marshall,Isabelle Logeart,Bonnie Vlahos,Jack F. Bukowski,Walter P. Maksymowych +15 more
TL;DR: In this article, the authors evaluated the long-term clinical and imaging efficacy of etanercept in patients with early, active nonradiographic axial spondyloarthritis (SpA).
Journal ArticleDOI
Recommandations de la Société francaise de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde
Cécile Gaujoux-Viala,Laure Gossec,Alain Cantagrel,Maxime Dougados,Bruno Fautrel,Xavier Mariette,Henri Nataf,Alain Saraux,Sonia Trope,Bernard Combe +9 more
TL;DR: Dans les 15 recommandations, il est propose de debuter par du methotrexate en monotherapie ; apres evaluation de la balance benefice-risque, les glucocorticoides peuvent etre associes sur une periode courte.